Navigation Links
Global Markets for Contract Pharmaceutical Manufacturing, Research and Packaging: Focus on Europe
Date:9/21/2011

NEW YORK, Sept. 21, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Global Markets for Contract Pharmaceutical Manufacturing, Research and Packaging: Focus on Europe

http://www.reportlinker.com/p0619262/Global-Markets-for-Contract-Pharmaceutical-Manufacturing-Research-and-Packaging-Focus-on-Europe.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Manufacturing

REPORT HIGHLIGHTS

* The global pharmaceutical contract manufacturing and contract research organizations revenue reached at $196.5 billion in 2010, it will further grow to $217.9 billion in 2011 and is projected to reach at $360.6 billion by 2016, increasing at a compound annual growth rate (CAGR) of 10.6%.

* The European contract manufacturing market for OTC and nutritional products was valued at about $46.0 billion in 2010 and is projected to reach approximately $51.3 in 2011 and it will further grow to $86.5 billion by 2016, at a compound annual growth rate (CAGR) of 11%.

* The contract research market revenue for Europe in 2009 was $5.8 billion, which reached $6.3 billion in 2010. This market is expected to reach at $6.9 billion in 2011 and it will further grow to $10.5 billion by 2016, at a compound annual growth rate (CAGR) of 8.7%.

INTRODUCTION

STUDY OBJECTIVE

The objective of BCC Research in conducting this study is to provide an overview of the current situation and future capabilities of the global pharmaceutical contract manufacturing, research, and packaging markets. The study provides a global as well as a regionally specific market overview. The report emphasizes the current and future outlook of the pharmaceutical contract manufacturing market, with a comprehensive analysis of the overall pharmaceutical and biotechnology outsourcing industry.

The current report discusses and outlines the current capabilities as well as the needs of the pharmaceutical contract manufacturing, research, and packaging markets. In addition, it discusses company and market strategies to further enhance the market. The report includes the different types of contract manufacturing and, more specifically, the services offered by global contract manufacturers, researchers, and packagers. The report also discusses the methods best used to identify an effective contract manufacturer as well as the advantages of contract manufacturing and outsourcing. The report highlights the need for project management, provides market forecasts for different aspects of contract manufacturing specific to each region, and examines the role of market leaders in the industry. Regulatory requirements and new developments in the market are also discussed in the report.

The report encompasses the revenues gained from contract manufacturing in each specific market and in each specific region. Sales analysis was performed on specific categories of drugs and dosage forms including API/bulk drugs and solid, liquid, and semisolid dosage forms. Sales analyses were also performed on revenues gained from contract packaging and contract research. The sales figures discussed are for the examined period of 2009 to 2011. Sales figures were also forecast for the following 5-year period from 2011 through 2016.

Over-the-counter (OTC) drugs, nutritional drugs, and drug delivery products are discussed in a separate section of this report.

REASONS FOR DOING THIS STUDY

The majority of pharmaceutical companies are now using contract manufacturing, research, and packaging services. To save costs and product development time while simultaneously being effective, efficient, and productive, pharmaceutical companies are relying on contract manufacturers to fulfill many basic as well as specialized competencies. This study discusses the different types of contracting companies, their roles, and the share of the market they claim. New developments and new technologies warrant the issuing of this report, which is an important resource for anyone analyzing the discussed markets.

Trends in outsourcing and new emerging markets for outsourcing are providing a new look to the market and greater options to pharmaceutical companies. The industry is seeing an increase in outsourcing as contract manufacturers, researchers, and packagers provide cheaper options as well as region-specific suppliers. The new state-of-the-art packaging facilities as well as expensive research facilities and capabilities of research organizations are enhancing the overall growth of the contract manufacturing industry. Contract manufacturers are providing pharmaceutical companies with expertise in all forms that the companies do not have available in-house.

INTENDED AUDIENCE

This study examines the areas of market growth in pharmaceuticals contract manufacturing, research, and packaging from the point of view of manufacturers and users. Strategic decision makers at biochemical and biotechnology companies, physicians, pharmaceuticals and biopharmaceuticals companies, and related research companies will find value in this study.

SCOPE OF THE STUDY

The scope of this study encompasses the contract manufacturing, research, and packaging markets. BCC analyzes each market and its applications for contract manufacturing by its need for outsourcing, regulatory environment, technology involved, market projections, and market share. Technological issues include the latest trends and developments.

METHODOLOGY

Both primary and secondary research methodologies were used in preparing this study. BCC conducted a comprehensive literature search, which included technical newsletters and journals, and many other sources. Data were collected through interviews and correspondence with various analytical, chemical, pharmaceutical, and contracting experts. Market sizing estimates and projections were based on estimates such as the current number of end users, potential end users, mergers and acquisitions, and market trends.

INFORMATION SOURCES

Many companies within the industry were surveyed to obtain data for this study. Included were manufacturers and end users of pharmaceuticals through contract manufacturing and research. Data were gathered from various industry sources. BCC spoke with officials and physicians within the industry, and consulted newsletters, company literature, product literature, and a host of technical articles, journals, indexes, and abstracts. Exhaustive investigations of databases by key terminology were completed. In addition, data were compiled from current financial, trade, and government sources.

CHAPTER ONE: INTRODUCTION

STUDY OBJECTIVE 1

REASONS FOR DOING THIS STUDY 1

INTENDED AUDIENCE 2

SCOPE OF THE STUDY 2

METHODOLOGY 2

INFORMATION SOURCES 3

ABOUT THE AUTHOR 3

RELATED BCC RESEARCH REPORTS 3

BCC ONLINE SERVICES 4

DISCLAIMER 4

CHAPTER TWO: SUMMARY 5

SUMMARY 5

SUMMARY (CONTINUED) 6

SUMMARY TABLE GLOBAL PHARMACEUTICAL CONTRACT

MANUFACTURING AND CONTRACT RESEARCH

ORGANIZATIONS REVENUE, THROUGH 2016 ($ BILLIONS) 7

SUMMARY FIGURE GLOBAL PHARMACEUTICAL CONTRACT

MANUFACTURING AND CONTRACT RESEARCH

ORGANIZATIONS REVENUE, 2009-2016 ($ BILLIONS) 7

CHAPTER THREE: OVERVIEW 8

DEFINITIONS 8

DEFINITIONS (CONTINUED) 9

HISTORY OF OUTSOURCING 10

TABLE 1 KEY DEVELOPMENTS IN THE HISTORY OF

OUTSOURCING 10

TABLE 1 (CONTINUED) 11

CHAPTER FOUR: OVERVIEW OF CONTRACT MANUFACTURING 12

TYPES OF CONTRACT MANUFACTURERS 12

CONTRACT MANUFACTURING TRAITS 12

REQUIREMENT 12

ABILITY TO BE FLEXIBLE 13

CAPABILITIES WITHOUT COST 13

ADVANTAGES AND DISADVANTAGES OF CONTRACT

MANUFACTURING 13

TABLE 2 KEY ADVANTAGES OF CONTRACT MANUFACTURING 14

TABLE 3 KEY DISADVANTAGES OF CONTRACT MANUFACTURING 14

SELECTING A CONTRACT MANUFACTURER 14

TABLE 4 KEY FACTORS IN SELECTING A CONTRACT

MANUFACTURER 15

TABLE 4 (CONTINUED) 16

ADDITIONAL FACTS ABOUT CONTRACT MANUFACTURING 16

LOCATION AND PROXIMITY 16

AFTER-SALES SUPPORT 16

CHAPTER FIVE: OVERVIEW OF CONTRACT RESEARCH 17

OVERVIEW OF CONTRACT RESEARCH 17

SERVICES OFFERED BY CONTRACT RESEARCH

ORGANIZATIONS 18

TABLE 5 SERVICES OF CONTRACT RESEARCH ORGANIZATIONS 18

TABLE 5 (CONTINUED) 19

SELECTING A CONTRACT RESEARCH ORGANIZATION 19

TABLE 6 KEY CHARACTERISTICS IN SELECTING A CONTRACT

RESEARCH ORGANIZATION 19

TABLE 6 (CONTINUED) 20

RESEARCH PROVIDED BY CONTRACT RESEARCH

ORGANIZATIONS 20

TABLE 7 TYPES OF RESEARCH PROVIDED BY CONTRACT

RESEARCH ORGANIZATIONS 20

TABLE 7 (CONTINUED) 21

CHAPTER SIX: OVERVIEW OF CONTRACT PACKAGING 22

NEEDING A CONTRACT PACKAGER 22

TABLE 8 REASONS BEHIND NEEDING A CONTRACT PACKAGER 22

TABLE 8 (CONTINUED) 23

SELECTING A CONTRACT PACKAGER 23

TABLE 9 KEY CHARACTERISTICS IN SELECTING A CONTRACT

PACKAGER 24

HIRING A CONTRACT PACKAGER 24

TABLE 10 KEY STEPS IN HIRING A CONTRACT PACKAGER 25

TYPES OF PACKAGING 25

TYPES OF PACKAGING (CONTINUED) 26

CHAPTER SEVEN: PROJECT MANAGEMENT 27

SPECIFICATIONS OF PROJECT MANAGEMENT 27

TABLE 11 STEPS OF PROJECT MANAGEMENT 27

TABLE 11 (CONTINUED) 28

PROCESSES OF PROJECT MANAGEMENT 28

TABLE 12 PROCESSES OF PROJECT MANAGEMENT 28

TABLE 12 (CONTINUED) 29

FACTORS INVOLVED 29

ROLE OF THE PROJECT MANAGER 29

TABLE 13 KEY RESPONSIBILITIES OF PROJECT MANAGERS 30

TECHNOLOGY TRANSFER 30

TABLE 14 TECHNOLOGY TRANSFER STEPS 31

CHAPTER EIGHT: REGULATORY ASPECTS 32

REGULATORY ASPECTS 32

TABLE 15 REGULATED FACTORS OF CMO'S AND CRO'S 33

TABLE 16 TITLE 21 CFR RULES ASSOCIATED WITH CONTRACT

MANUFACTURING 33

TABLE 16 (CONTINUED) 34

TABLE 16 (CONTINUED) 35

WARNING LETTERS 36

TABLE 17 WARNING LETTERS ISSUED TO CONTRACT

MANUFACTURERS, 2010 36

TABLE 18 WARNING LETTERS ISSUED TO CONTRACT

MANUFACTURERS, 2009 37

REGULATORY APPROVALS 37

TABLE 19 REGULATORY APPROVALS OF CONTRACT

MANUFACTURERS AND FACILITIES, JANUARY THROUGH

MARCH, 2011 38

TABLE 20 REGULATORY APPROVALS OF CONTRACT

MANUFACTURERS AND FACILITIES, 2010 38

TABLE 20 (CONTINUED) 39

TABLE 21 REGULATORY APPROVALS OF CONTRACT

MANUFACTURERS AND FACILITIES, 2009 39

TABLE 21 (CONTINUED) 40

CHAPTER NINE: INDUSTRY STRUCTURE FOR EUROPE 41

MARKET SHARE OF INDUSTRY LEADERS 41

CONTRACT MANUFACTURERS OF BULK DRUGS AND API'S 41

TABLE 22 MARKET SHARE OF CONTRACT MANUFACTURING

COMPANIES PROVIDING BULK DRUGS/API'S, IN EUROPE, 2010

(%) 41

TABLE 22 (CONTINUED) 42

FIGURE 1 MARKET SHARE OF CONTRACT MANUFACTURING

COMPANIES PROVIDING BULK DRUGS/API'S, IN EUROPE, 2010

(%) 42

CONTRACT MANUFACTURERS OF SOLID DOSAGE FORMS 42

TABLE 23 MARKET SHARE OF CONTRACT MANUFACTURING

COMPANIES PROVIDING SOLID DOSAGE FORMS, IN EUROPE,

2010 (%) 43

FIGURE 2 MARKET SHARE OF CONTRACT MANUFACTURING

COMPANIES PROVIDING SOLID DOSAGE FORMS, IN EUROPE,

2010 (%) 43

CONTRACT MANUFACTURERS OF LIQUID DOSAGE FORMS 44

NONSTERILE 44

TABLE 24 MARKET SHARE OF CONTRACT MANUFACTURING

COMPANIES PROVIDING NONSTERILE LIQUID DOSAGE FORMS,

IN EUROPE, 2010 (%) 44

FIGURE 3 MARKET SHARE OF CONTRACT MANUFACTURING

COMPANIES PROVIDING NONSTERILE LIQUID DOSAGE FORMS,

IN EUROPE, 2010 (%) 45

STERILE 45

TABLE 25 MARKET SHARE OF CONTRACT MANUFACTURING

COMPANIES PROVIDING STERILE LIQUID DOSAGE FORMS, IN

EUROPE, 2010 (%) 46

FIGURE 4 MARKET SHARE OF CONTRACT MANUFACTURING

COMPANIES PROVIDING STERILE LIQUID DOSAGE FORMS, IN

EUROPE, 2010 (%) 46

CONTRACT MANUFACTURING OF SEMISOLID DOSAGE FORMS 47

TABLE 26 MARKET SHARE OF CONTRACT MANUFACTURING

COMPANIES PROVIDING SEMISOLID DOSAGE FORMS, IN

EUROPE, 2010 (%) 47

FIGURE 5 MARKET SHARE OF CONTRACT MANUFACTURING

COMPANIES PROVIDING SEMISOLID DOSAGE FORMS, IN

EUROPE, 2010 (%) 47

CONTRACT RESEARCH COMPANIES 48

TABLE 27 MARKET SHARE OF CONTRACT RESEARCH

COMPANIES, IN EUROPE, 2010 (%) 48

FIGURE 6 MARKET SHARE OF CONTRACT RESEARCH

COMPANIES, IN EUROPE, 2010 (%) 49

TABLE 28 MARKET SHARE OF CONTRACT PACKAGING

COMPANIES, IN EUROPE, 2010 (%) 50

FIGURE 7 MARKET SHARE OF CONTRACT PACKAGING

COMPANIES, IN EUROPE, 2010 (%) 50

CHAPTER TEN: TECHNOLOGY TRANSFER 51

REASONS FOR TECHNOLOGY TRANSFER 51

CHALLENGING PROBLEMS DURING TECHNOLOGY TRANSFER 52

TECHNOLOGY TRANSFER 53

STEPS FOR SUCCESSFUL TECHNOLOGY TRANSFER 53

TYPES OF CONTRACTUAL AGREEMENTS USED IN

TECHNOLOGY TRANSFER 54

CONFIDENTIAL DISCLOSURE AGREEMENT (CDA) 55

MATERIAL TRANSFER AGREEMENT (MTA) 55

ASSIGNMENT DEED 55

LICENSE AGREEMENT 56

CO-DEVELOPMENT AND CO-MARKETING AGREEMENTS 56

CHARACTERISTICS OF A SUCCESSFUL PROJECT 56

CHARACTERISTICS OF A SUCCESSFUL … (CONTINUED) 57

CHAPTER ELEVEN: NEW DEVELOPMENTS 58

LONZA 58

ABBOTT 59

HOSPIRA 60

COVIDIEN 60

OTHER 61

OTHER (CONTINUED) 62

CHAPTER TWELVE: MARKET ANALYSIS FOR EUROPE 63

CONTRACT MANUFACTURING 63

CONTRACT MANUFACTURE OF BULK DRUGS/API'S 63

Market Overview 63

Market Revenue 64

TABLE 29 BULK DRUG/API CONTRACT MANUFACTURING

REVENUE, FOR EUROPE, THROUGH 2016 ($ BILLIONS) 64

FIGURE 8 BULK DRUG/API CONTRACT MANUFACTURING

REVENUE, FOR EUROPE, 2009-2016 ($ BILLIONS) 65

CONTRACT MANUFACTURE OF ORAL DOSAGE

FORMULATIONS 65

Solid Dosage Formulations 66

Market Overview 66

Market Revenue 67

TABLE 30 SOLID DOSAGE FORM CONTRACT MANUFACTURING,

FOR EUROPE, THROUGH 2016 ($ BILLIONS) 67

FIGURE 9 SOLID DOSAGE FORM CONTRACT MANUFACTURING,

FOR EUROPE, 2009- 2016 ($ BILLIONS) 68

Market by Formulation 68

Market Revenue 69

TABLE 31 SOLID DOSAGE FORM CONTRACT MANUFACTURING

REVENUE, BY FORMULATION, FOR EUROPE, THROUGH 2016 ($

BILLIONS) 69

FIGURE 10 SOLID DOSAGE FORM CONTRACT MANUFACTURING

REVENUE, BY FORMULATIONS, FOR EUROPE, 2009-2016 ($

BILLIONS) 70

TABLE 32 SOLID DOSAGE FORM CONTRACT MANUFACTURING

MARKET SHARES, BY FORMULATION, FOR EUROPE, 2010 (%) 70

FIGURE 11 SOLID DOSAGE FORM CONTRACT MANUFACTURING

MARKET SHARES, BY FORMULATIONS, FOR EUROPE, 2010 (%) 71

Liquid Dosage Formulation 71

Market Overview 71

Market Revenue 72

Nonsterile Formulations 72

TABLE 33 LIQUID DOSAGE FORM (NONSTERILE) CONTRACT

MANUFACTURING, FOR EUROPE, THROUGH 2016 ($ MILLIONS) 73

FIGURE 12 LIQUID DOSAGE FORM (NONSTERILE) CONTRACT

MANUFACTURING, FOR EUROPE, 2009-2016 ($ MILLIONS) 73

Sterile Formulations 73

TABLE 34 LIQUID DOSAGE FORM (STERILE) CONTRACT

MANUFACTURING, FOR EUROPE, THROUGH 2016 ($ MILLIONS) 74

FIGURE 13 LIQUID DOSAGE FORM (STERILE) CONTRACT

MANUFACTURING, FOR EUROPE, 2009-2016 ($ MILLIONS) 74

Market by Formulation 74

Nonsterile Formulations 74

TABLE 35 LIQUID DOSAGE FORM (NONSTERILE) CONTRACT

MANUFACTURING REVENUE, BY FORMULATION, FOR EUROPE,

THROUGH 2016 ($ MILLIONS) 75

FIGURE 14 LIQUID DOSAGE FORM (NONSTERILE) CONTRACT

MANUFACTURING REVENUE, BY FORMULATIONS, FOR

EUROPE, 2009-2016 ($ MILLIONS) 76

TABLE 36 LIQUID DOSAGE FORM (NONSTERILE) CONTRACT

MANUFACTURING MARKET SHARES, BY FORMULATION, FOR

EUROPE, 2010 (%) 76

FIGURE 15 LIQUID DOSAGE FORM (NONSTERILE) CONTRACT

MANUFACTURING MARKET SHARES, BY FORMULATIONS, FOR

EUROPE, 2010 (%) 77

Sterile Formulations 77

TABLE 37 LIQUID DOSAGE FORM (STERILE) CONTRACT

MANUFACTURING REVENUE, BY FORMULATION, FOR EUROPE,

THROUGH 2016 ($ MILLIONS) 78

FIGURE 16 LIQUID DOSAGE FORM (STERILE) CONTRACT

MANUFACTURING REVENUE, BY FORMULATION, FOR EUROPE,

2009-2016 ($ MILLIONS) 78

TABLE 38 LIQUID DOSAGE FORM (STERILE) CONTRACT

MANUFACTURING MARKET SHARE, BY FORMULATION, FOR

EUROPE, 2010 (%) 79

FIGURE 17 LIQUID DOSAGE FORM (STERILE) CONTRACT

MANUFACTURING MARKET SHARE, BY FORMULATIONS, FOR

EUROPE, 2010 (%) 79

CONTRACT MANUFACTURE OF SEMISOLID DOSAGE

FORMULATIONS 79

Market Overview 79

Market Revenue 80

TABLE 39 SEMISOLID DOSAGE FORM CONTRACT

MANUFACTURING, FOR EUROPE, THROUGH 2016 ($ MILLIONS) 81

FIGURE 18 SEMISOLID DOSAGE FORM CONTRACT

MANUFACTURING, FOR EUROPE, 2009-2016 ($ MILLIONS) 81

TABLE 40 SEMISOLID DOSAGE FORM CONTRACT

MANUFACTURING REVENUE, BY FORMULATION, FOR

EUROPE, THROUGH 2016 ($ MILLIONS) 82

FIGURE 19 SEMISOLID DOSAGE FORM CONTRACT

MANUFACTURING REVENUE, BY FORMULATIONS, FOR

EUROPE, 2009-2016 ($ MILLIONS) 82

TABLE 41 SEMISOLID DOSAGE FORM CONTRACT

MANUFACTURING MARKET SHARE, BY FORMULATION, FOR

EUROPE, 2010 (%) 83

FIGURE 20 SEMISOLID DOSAGE FORM CONTRACT

MANUFACTURING MARKET SHARE, BY FORMULATIONS, FOR

EUROPE, 2010 (%) 83

CONTRACT MANUFACTURE OF ADVANCED DRUG

DELIVERY PRODUCTS 83

Market Overview 84

TABLE 42 CONTRACTING COMPANIES PROVIDING DRUG

DELIVERY SYSTEMS 85

Market Revenue 85

TABLE 43 ADVANCED DRUG DELIVERY SYSTEMS REVENUE, BY

CONTRACT MANUFACTURING, FOR EUROPE, THROUGH 2016 ($

BILLIONS) 86

FIGURE 21 ADVANCED DRUG DELIVERY SYSTEMS REVENUE, BY

CONTRACT MANUFACTURING, FOR EUROPE, 2009-2016 ($

BILLIONS) 86

Market by Formulation 86

TABLE 44 ADVANCED DRUG DELIVERY SYSTEMS BY CONTRACT

MANUFACTURING REVENUE, BY FORMULATION, FOR EUROPE,

THROUGH 2016 ($ MILLIONS) 87

FIGURE 22 ADVANCED DRUG DELIVERY SYSTEMS BY CONTRACT

MANUFACTURING REVENUE, BY FORMULATIONS, FOR

EUROPE, 2009-2016 ($ MILLIONS) 88

Market Share 88

TABLE 45 ADVANCED DRUG DELIVERY SYSTEMS BY CONTRACT

MANUFACTURING MARKET SHARE, BY FORMULATION, FOR

EUROPE, 2010 (%) 89

FIGURE 23 ADVANCED DRUG DELIVERY SYSTEMS BY CONTRACT

MANUFACTURING MARKET SHARE, BY FORMULATIONS, FOR

EUROPE, 2010 (%) 89

CONTRACT MANUFACTURE OF OTC AND NUTRITIONAL

PRODUCTS 90

Market Revenue 91

TABLE 46 OTC AND NUTRITIONAL PRODUCTS REVENUE, BY

CONTRACT MANUFACTURING, FOR EUROPE, THROUGH 2016 ($

BILLIONS) 91

FIGURE 24 OTC AND NUTRITIONAL PRODUCTS REVENUE, BY

CONTRACT MANUFACTURING, FOR EUROPE, 2009-2016 ($

BILLIONS) 91

Market by Formulation 92

TABLE 47 OTC AND NUTRITIONAL PRODUCTS BY CONTRACT

MANUFACTURING REVENUE, BY FORMULATION, FOR EUROPE,

THROUGH 2016 ($ BILLIONS) 92

FIGURE 25 OTC AND NUTRITIONAL PRODUCTS BY CONTRACT

MANUFACTURING REVENUE, BY FORMULATIONS, FOR

EUROPE, 2009-2016 ($ BILLIONS) 93

Market Shares 93

TABLE 48 OTC AND NUTRITIONAL PRODUCTS BY CONTRACT

MANUFACTURING MARKET SHARE, BY FORMULATION, FOR

EUROPE, 2010 (%) 93

FIGURE 26 OTC AND NUTRITIONAL PRODUCTS BY CONTRACT

MANUFACTURING MARKET SHARE, BY FORMULATIONS, FOR

EUROPE, 2010 (%) 94

CONTRACT RESEARCH 94

MARKET OVERVIEW 94

Partnerships 94

Expansions of Facilities 95

Market Revenue 95

TABLE 49 CONTRACT RESEARCH REVENUE, FOR EUROPE,

THROUGH 2016 ($ BILLIONS) 96

FIGURE 27 CONTRACT RESEARCH REVENUE, FOR EUROPE, 2009-

2016 ($ BILLIONS) 96

Market by Discipline 96

TABLE 50 CONTRACT RESEARCH REVENUE BY DISCIPLINE, FOR

EUROPE, THROUGH 2016 ($ MILLIONS) 97

FIGURE 28 CONTRACT RESEARCH REVENUE BY DISCIPLINE, FOR

EUROPE, 2009-2016 ($ MILLIONS) 97

Market Share by Discipline 98

TABLE 51 CONTRACT RESEARCH MARKET SHARE, BY

DISCIPLINE, FOR EUROPE, 2010 (%) 98

FIGURE 29 CONTRACT RESEARCH MARKET SHARE, BY

DISCIPLINE, FOR EUROPE, 2010 (%) 98

CONTRACT PACKAGING 99

MARKET OVERVIEW 99

Market Revenue 99

TABLE 52 CONTRACT PACKAGING REVENUE, FOR EUROPE,

THROUGH 2016 ($ BILLIONS) 100

FIGURE 30 CONTRACT PACKAGING REVENUE, FOR EUROPE, 2009-

2016 ($ BILLIONS) 100

Market by Package Type 100

TABLE 53 CONTRACT PACKAGING REVENUE BY TYPE, FOR

EUROPE, THROUGH 2016 ($ MILLIONS) 101

FIGURE 31 CONTRACT RESEARCH REVENUE BY DISCIPLINE, FOR

EUROPE, 2009-2016 ($ BILLIONS) 102

Market Share by Type 102

TABLE 54 CONTRACT PACKAGING MARKET SHARE BY TYPE, FOR

EUROPE, 2010 (%) 103

FIGURE 32 CONTRACT PACKAGING MARKET SHARE BY TYPE, FOR

EUROPE, 2010 (%) 103

CHAPTER THIRTEEN: MARKET SHARE BY REGION 104

MARKET SHARE OF CONTRACT MANUFACTURED API'S 104

TABLE 55 BULK DRUG/API CONTRACT MANUFACTURING

MARKET SHARE, BY REGION, 2010 (%) 104

FIGURE 33 BULK DRUG/API CONTRACT MANUFACTURING

MARKET SHARE, BY REGION, 2010 (%) 105

MARKET SHARE OF CONTRACT MANUFACTURED SOLID

DOSAGE FORMS 105

TABLE 56 SOLID DOSAGE FORM CONTRACT MANUFACTURING

MARKET SHARE, BY REGION, 2010 (%) 105

FIGURE 34 SOLID DOSAGE FORM CONTRACT MANUFACTURING

MARKET SHARE, BY REGION, 2010 (%) 106

MARKET SHARE OF CONTRACT MANUFACTURED LIQUID

DOSAGE FORMULATIONS 106

NONSTERILE FORMULATIONS 106

TABLE 57 LIQUID DOSAGE FORM (NONSTERILE) CONTRACT

MANUFACTURING MARKET SHARE, BY REGION, 2010 (%) 106

FIGURE 35 LIQUID DOSAGE FORM (NONSTERILE) CONTRACT

MANUFACTURING MARKET SHARE, BY REGION, 2010 (%) 107

STERILE FORMULATIONS 107

TABLE 58 LIQUID DOSAGE FORM (STERILE) CONTRACT

MANUFACTURING MARKET SHARE, BY REGION, 2010 (%) 107

FIGURE 36 LIQUID DOSAGE FORM (STERILE) CONTRACT

MANUFACTURING MARKET SHARE, BY REGION, 2010 (%) 108

MARKET SHARE OF CONTRACT MANUFACTURED SEMISOLID

DOSAGE FORMULATIONS 108

TABLE 59 SEMISOLID DOSAGE FORM CONTRACT

MANUFACTURING MARKET SHARES, BY REGION, 2010 (%) 108

FIGURE 37 SEMISOLID DOSAGE FORM CONTRACT

MANUFACTURING MARKET SHARE, BY REGION, 2010 (%) 109

MARKET SHARE OF CONTRACT MANUFACTURED ADVANCED

DRUG DELIVERY PRODUCTS 109

TABLE 60 DRUG DELIVERY CONTRACT MANUFACTURING

MARKET SHARE, BY REGION, 2010 (%) 109

FIGURE 38 DRUG DELIVERY CONTRACT MANUFACTURING

MARKET SHARE, BY REGION, 2010 (%) 110

MARKET SHARE OF CONTRACT MANUFACTURED OTC AND

NUTRITIONAL PRODUCTS 110

TABLE 61 OTC AND NUTRITIONAL PRODUCTS CONTRACT

MANUFACTURING MARKET SHARE, BY REGION, 2010 (%) 110

FIGURE 39 OTC AND NUTRITIONAL PRODUCT CONTRACT

MANUFACTURING MARKET SHARE, BY REGION, 2010 (%) 111

MARKET SHARE OF CONTRACT RESEARCH 111

TABLE 62 CONTRACT RESEARCH MARKET SHARE, BY REGION,

2010 (%) 111

FIGURE 40 CONTRACT RESEARCH MARKET SHARE, BY REGION,

2010 (%) 112

MARKET SHARE OF CONTRACT PACKAGING 112

TABLE 63 CONTRACT PACKAGING MARKET SHARE, BY REGION,

2010 (%) 112

FIGURE 41 CONTRACT PACKAGING MARKET SHARE, BY REGION,

2010 (%) 113

CHAPTER FOURTEEN: CONTRACT MANUFACTURING APPLICATIONS

FOR EUROPEAN MARKETS 114

CARDIOVASCULAR DRUGS 114

MARKET REVENUE 115

TABLE 64 REVENUE FROM CONTRACT MANUFACTURERS OF

CARDIOVASCULAR DRUGS, IN EUROPE, THROUGH 2016 ($

MILLIONS) 115

FIGURE 42 REVENUE FROM CONTRACT MANUFACTURERS OF

CARDIOVASCULAR DRUGS, IN EUROPE, 2009-2016 ($ MILLIONS) 116

REPRODUCTIVE DRUG MARKET 116

MARKET REVENUE 117

TABLE 65 REVENUE FROM CONTRACT MANUFACTURERS OF

REPRODUCTIVE DRUGS, IN EUROPE, THROUGH 2016 ($

MILLIONS) 118

FIGURE 43 REVENUE FROM CONTRACT MANUFACTURERS OF

REPRODUCTIVE DRUGS, IN EUROPE, 2009-2016 ($ MILLIONS) 118

ONCOLOGY DRUG MARKET 118

MARKET REVENUE 119

TABLE 66 REVENUE FROM CONTRACT MANUFACTURERS OF

ONCOLOGY DRUGS, IN EUROPE, THROUGH 2016 ($ MILLIONS) 120

FIGURE 44 REVENUE FROM CONTRACT MANUFACTURERS OF

ONCOLOGY DRUGS, IN EUROPE, 2009-2016 ($ MILLIONS) 120

ANALGESICS MARKET 120

MARKET REVENUE 121

TABLE 67 REVENUE FROM CONTRACT MANUFACTURERS OF

ANALGESICS, IN EUROPE, THROUGH 2016 ($ MILLIONS) 121

FIGURE 45 REVENUE FROM CONTRACT MANUFACTURERS OF

ANALGESICS, IN EUROPE, 2009-2016 ($ MILLIONS) 122

ANTIVIRAL DRUG MARKET 122

MARKET REVENUE 123

TABLE 68 REVENUE FROM CONTRACT MANUFACTURERS OF

ANTIVIRALS, IN EUROPE, THROUGH 2016 ($ MILLIONS) 123

FIGURE 46 REVENUE FROM CONTRACT MANUFACTURERS OF

ANTIVIRALS, IN EUROPE, 2009-2016 ($ MILLIONS) 124

ANTIBIOTICS MARKET 124

MARKET REVENUE 125

TABLE 69 REVENUE FROM CONTRACT MANUFACTURERS OF

ANTIBIOTICS, IN EUROPE, THROUGH 2016 ($ MILLIONS) 125

FIGURE 47 REVENUE FROM CONTRACT MANUFACTURERS OF

ANTIBIOTICS, IN EUROPE, 2009-2016 ($ MILLIONS) 125

MARKETS FOR OTHER DRUGS 126

MARKET REVENUE 126

TABLE 70 REVENUE FROM CONTRACT MANUFACTURERS OF

OTHER DRUGS, IN EUROPE, THROUGH 2016 ($ BILLIONS) 126

FIGURE 48 REVENUE FROM CONTRACT MANUFACTURERS OF

OTHER DRUGS, IN EUROPE, 2009-2016 ($ BILLIONS) 127

CHAPTER FIFTEEN: PATENT ANALYSIS 128

PATENTS BY YEAR 128

TABLE 71 NUMBER OF SIGNIFICANT PATENTS, BY YEAR, 2009-

2011 128

FIGURE 49 NUMBER OF PATENTS, BY YEAR, 2009-MAY 31, 2011 128

FIGURE 50 NUMBER OF PATENTS, BY YEAR, 2009-MAY 31, 2011 (%) 129

PATENTS BY COMPANY 129

TABLE 72 NUMBER OF US PATENTS, BY COMPANY, 2009-2011 130

FIGURE 51 NUMBER OF US PATENTS, BY COMPANY, 2009-2011 131

PATENTS BY COUNTRY 132

TABLE 73 NUMBER OF US PATENTS, BY COUNTRY, 1/1/2009 TO

5/31/2011 132

FIGURE 52 NUMBER OF US PATENTS, BY COUNTRY, 1/1/2009 TO

5/31/2011 133

TABLE 74 PATENT SHARES, BY COUNTRY, 1/1/2009 TO 5/31/2011

(%) 133

FIGURE 53 PATENT SHARES, BY COUNTRY, 1/1/2009 TO

5/31/2011 (%) 134

PATENTS BY EMPHASIS 134

TABLE 75 PATENTS, BY EMPHASIS, 1/1/2009 TO 5/31/2011 135

FIGURE 54 NUMBER OF US PATENTS, BY EMPHASIS, 1/1/2009 TO

5/31/2011 135

CHAPTER SIXTEEN: CURRENT ENVIRONMENT 136

SITUATION OF THE NORTH AMERICAN CONTRACTING

MARKETS 136

CONTRACT MANUFACTURING OF API AND DOSAGE

FORMS 136

CONTRACT MANUFACTURING OF OTC AND

NUTRACEUTICALS 136

CONTRACT RESEARCH 137

CONTRACT PACKAGING 137

SITUATION OF THE EUROPEAN CONTRACTING MARKET 137

CONTRACT MANUFACTURING OF API AND DOSAGE

FORMS 137

CONTRACT MANUFACTURING OF OTC AND

NUTRACEUTICALS 137

CONTRACT RESEARCH 138

CONTRACT PACKAGING 138

SITUATION OF THE ROW CONTRACTING MARKET 138

CONTRACT MANUFACTURING OF API AND DOSAGE

FORMS 138

CONTRACT MANUFACTURING OF OTC AND

NUTRACEUTICALS 138

CONTRACT RESEARCH 139

CONTRACT PACKAGING 139

OPPORTUNITIES AND CHALLENGES OF THE CURRENT

CONTRACT MANUFACTURING INDUSTRY 139

OPPORTUNITIES AND CHALLENGES…(CONTINUED) 140

OPPORTUNITIES AND CHALLENGES…(CONTINUED) 141

CHAPTER SEVENTEEN: COMPANY PROFILES 142

AAI PHARMA, INC 142

ABBOTT LABORATORIES 142

AEROGEN LTD 143

ALKERMES 143

ALTHEA TECHNOLOGIES 144

AMCOR 145

AMERISOURCE BERGEN CORPORATION 145

AMPAC FINE CHEMICALS 146

ALBANY MOLECULAR RESEARCH INC (AMRI) 146

AP PHARMA INC 147

APTUIT INC 147

ARADIGM CORPORATION 148

BASF SE 149

BAXTER HEALTHCARE 149

BCM/BOOTS MANUFACTURING 150

BOEHRINGER INGELHEIM 151

BRISTOL-MYERS SQUIBB 151

CAMBREX CORPORATION 152

CANGENE CORPORATION 153

CATALENT PHARMA SOLUTIONS 153

CEDARBURG HAUSER PHARMACEUTICALS INC 154

CENEXI 154

CHARLES RIVER LABORATORIES 155

CHEMBRIDGE CORP 155

CLEARSTONE CENTRAL LABORATORIES 156

CONFAB LABORATORIES 156

COVANCE INC 157

COVIDIEN 157

CONTRACT PHARMACEUTICALS LIMITED 158

CORDEN PHARMA SWITZERLAND LLC 158

DAVOS PHARMA 159

DECODE GENETICS 159

DISHMAN PHARMACEUTICALS AND CHEMICALS LTD 160

DOW CHEMICAL 161

DPT LABORATORIES INC 161

DR REDDY'S LABORATORIES 162

DSM PHARMACEUTICAL PRODUCTS 162

FUJIFILM DIOSYNTH BIOTECHNOLOGY 163

ELAN DRUG TECHNOLOGIES 163

EVOTEC AG 164

FULCRUM PHARMA PLC 164

GIRINDUS AG 165

GLAXOSMITHKLINE 165

HOSPIRA 166

HAUPT PHARMA AG 167

HOVIONE SA 167

ICON PLC 168

INC RESEARCH, INC 168

JUBILANT LIFESCIENCES 169

KENDLE INTERNATIONAL INC 169

KP PHARMACEUTICAL TECHNOLOGIES INC 170

KV PHARMACEUTICAL CO 170

LIGAND PHARMACEUTICALS, INC 171

LONZA GROUP 171

LYNE LABORATORIES 172

MERCK / MSD BIOMANUFACTURING NETWORK 173

MIKART INC 173

NEXTPHARMA TECHNOLOGIES 174

NORWICH PHARMACEUTICALS 174

NOVAVAX, INC 175

OMNICARE CLINICAL RESEARCH 175

PAREXEL INTERNATIONAL CORPORATION 176

PATHEON INC 176

PERRIGO COMPANY 177

PFIZER (KING PHARMACEUTICALS 178

PIRAMAL HEALTHCARE LIMITED 178

PPD 179

PRA INTERNATIONAL 179

QUINTILES 180

RANBAXY 180

REGIS TECHNOLOGIES, INC 181

SKYEPHARMA 181

TALECRIS BIOTHERAPEUTICS INC 182

VETTER PHARMA INTERNATIONAL GMBH 182

WOCKHARDT LIMITED 183

WUXI APP TEC 184

XCELLEREX LLC 184

ZACH SYSTEM SPA 185

APPENDIX I: ABBREVIATIONS 186

To order this report:

Manufacturing Industry: Global Markets for Contract Pharmaceutical Manufacturing, Research and Packaging: Focus on Europe

Manufacturing Business News

More  Industry Analysis and Insights

Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved


Related medicine technology :

1. Prosthetic Heart Valves - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
2. Questcor Pharmaceuticals to Present at the Jefferies Global Healthcare Conference on September 28, 2011
3. Accuray Incorporated to Speak at UBS Global Life Sciences Conference
4. Unilife to Present at the 2011 UBS Global Life Sciences Conference in New York City
5. Aperion Biologics Invited to Present at the UBS Global Life Sciences Conference
6. Jazz Pharmaceuticals Announces Presentation at the UBS Global Life Sciences Conference in New York on September 20
7. Regeneron Ranked by Science Magazine as the #2 Employer in the Global Biopharmaceutical Industry
8. ClinStar to Present on Russias Performance as an Emerging Market in Global Clinical Trials
9. Global Blood Glucose Test Strips Market 2010-2014
10. Global Peripheral Vascular Devices Market 2010-2014
11. Global Digital Radiography Market 2010-2014
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... IRVINE, Calif., Feb. 11, 2016 PRO-DEX, INC. (NasdaqCM: ... quarter ended December 31, 2015. The Company also filed its ... fiscal year 2016 with the Securities and Exchange Commission today. ... December 31, 2015 --> --> ... 2015 increased $2.6 million, or 95%, to $5.4 million from ...
(Date:2/11/2016)... , Feb. 11, 2016   Health 2.0 , ... new health technologies, announced today " 10 Year Global ... health tech over the past ten years.   ... a decade, Health 2.0 has served as the preeminent ... connected with thousands of technologies, companies, innovators, and patient-activists ...
(Date:2/11/2016)... , Feb. 11, 2016  AfterPill.com is reporting that ... alcohol abstinence for all women who are at risk ... U.S. each year and raises the risks of unprotected ... --> According to the Guttmacher Institute, there ... women of child-bearing age, who have sex without the ...
Breaking Medicine Technology:
(Date:2/13/2016)... ... 2016 , ... Hidden Cypress in Sun City is the place to be on March 3rd ... Frederick Weniger will be hosting this educational seminar from 5:30 p.m. – 7:00 p.m. ... special pricing on offers. In addition, prizes will be given away and light refreshments will ...
(Date:2/13/2016)... ... ... individuals looking to lead a healthy lifestyle have decreased carbohydrate consumption and increased their ... delved into this niche allowing those giving up their beloved pasta a chance to ... of protein and only 7 grams of carbohydrates per 50 gram serving--a ratio that ...
(Date:2/13/2016)... Tennessee (PRWEB) , ... February 13, 2016 , ... ... the Infusion Nurses Society (INS) states that vein visualization technology should be used ... by healthcare facilities around the world, the INS Standards mandate the use of ...
(Date:2/13/2016)... ... , ... In the early or “honeymoon” stage of a relationship, couples strive ... their way to be romantic, and may exaggerate a strength or two in an ... profile. , A recent study from Queendom.com , however, suggests that new ...
(Date:2/12/2016)... Antonio, TX (PRWEB) , ... February 12, 2016 , ... ... love, as expressed in Blue SKies Buddha, the biography of Rama - Dr. Frederick ... fact a love story, the love of a Buddhist teacher for teaching and helping ...
Breaking Medicine News(10 mins):